A. Uzan

发表

Enoxaparin in Experimental Stroke: Neuroprotection and Therapeutic Window of Opportunity

V. Mary, F. Wahl, A. Uzan, 2001, Stroke.

"Peripheral type" benzodiazepine binding sites in rat adrenals: binding studies with [3H]PK 11195 and autoradiographic localization.

J. Bénavidès, G. Le Fur, A. Uzan, 1983, Archives internationales de pharmacodynamie et de therapie.

[Introduction. Epidemiology].

A. Uzan, G. Blancher, A Uzan, 2004, Annales pharmaceutiques francaises.

Plasma free 5-hydroxytryptamine (5-HT): evidence of an increase induced by LM 5008, a potent 5-HT uptake inhibitor.

G. Le Fur, A. Uzan, M. Kabouche, 1978, Life sciences.

PK 11195, an antagonist of peripheral type benzodiazepine receptors, modulates Bay K8644 sensitive but not beta- or H2-receptor sensitive voltage operated calcium channels in the guinea pig heart.

G. Néliat, G. Le Fur, A. Uzan, 1986, Life sciences.

On the Relationship Between Molecular Mass and Anticoagulant Activity in a Low Molecular Weight Heparin (Enoxaparin)

E. Pacaud, H. Hemker, S. Béguin, 1992, Thrombosis and Haemostasis.

Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies.

J. Bénavidès, P. Rufat, G. Le Fur, 1983, Life sciences.

Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in a guinea pig heart preparation.

G. Le Fur, A. Uzan, C. Renault, 1984, Life sciences.

In vivo labelling in several rat tissues of 'peripheral type' benzodiazepine binding sites.

J. Bénavidès, G. Fur, P. Rufat, 1984, European journal of pharmacology.

Electrophysiological and pharmacological evidence that peripheral type benzodiazepine receptors are coupled to calcium channels in the heart.

G. Le Fur, A. Uzan, C. Renault, 1985, Life sciences.

Dihydropyridine and peripheral type benzodiazepine binding sites: subcellular distribution and molecular size determination.

J. Bénavidès, G. Le Fur, A. Uzan, 1985, European journal of pharmacology.

Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review.

V. Mary, F. Wahl, A. Uzan, 2006, CNS drug reviews.

Enoxaparin Reduces Cerebral Edemaafter Photothrombotic Injury in the Rat

A. Imperato, A. Uzan, J. Stutzmann, 1998, Pathophysiology of Haemostasis and Thrombosis.

Intravenous aspirin at reperfusion does not reduce infarct size in the dog with a residual critical stenosis.

A. Uzan, Y. Merhi, J. Latour, 1999, Journal of cardiovascular pharmacology.

In vivo blockade of dopaminergic receptors from different rat brain regions by classical and atypical neuroleptics.

G. Le Fur, A. Uzan, F. Guilloux, 1980, Biochemical pharmacology.

The low molecular weight heparin, enoxaparin, limits infarct size at reperfusion in the dog.

A. Uzan, J. Latour, P. Dagenais, 1998, Cardiovascular research.

Central dopaminergic neurons during development of genetic and DOCA-salt hypertension in the rat.

G. Le Fur, A. Uzan, M. Kabouche, 1981, Brain research.

Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils

A. Uzan, P. Laduron, C. Malgouris, 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Comparative effects of heparin and PK 10169, a low molecular weight fraction, in a canine model of arterial thrombosis.

G. Le Fur, A. Uzan, M. Mestre, 1985, Thrombosis research.

Enoxaparin (Clexane, Lovenox), a low molecular weight heparin, enhances t-PA-induced coronary thrombus lysis in anesthetized dogs without inducing hypocoagulability.

A. Uzan, P. Sedivy, I. Cavero, 1992, Thrombosis research.

Enoxaparin reduces brain edema, cerebral lesions, and improves motor and cognitive impairments induced by a traumatic brain injury in rats.

F. Wahl, A. Uzan, J. Stutzmann, 2000, Journal of neurotrauma.

Autoradiographic localization of peripheral benzodiazepine binding sites in the cat brain with [3H]PK 11195

M. Desban, J. Bénavidès, G. Fur, 1984, Brain Research Bulletin.

PK 11195, an antagonist of peripheral benzodiazepine receptors, reduces ventricular arrhythmias during myocardial ischemia and reperfusion in the dog.

G. Fur, G. Bouétard, G. Le Fur, 1985, European journal of pharmacology.

Effects of 4-(3-indolyl-alkyl)piperidine derivatives on uptake and release of noradrenaline, dopamine and 5-hydroxytryptamine in rat brain synaptosomes, rat heart and human blood platelets.

G. Le Fur, A. Uzan, 1977, Biochemical pharmacology.

Physiopathological Significance of Catalytic Phospholipids in the Generation of Thrombin

J. Freyssinet, A. Uzan, F. Toti, 1996, Seminars in thrombosis and hemostasis.

Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitor.

M. Bloch, A. Uzan, M. Samama, 1993, Thrombosis research.

Identification of stereospecific [3H]spiroperidol binding sites in mammalian lymphocytes.

G. Le Fur, A. Uzan, T. Phan, 1980, Life sciences.

A subacute treatment of L-methionine induces an increase in the number of [3H]spiperone binding sites in the striatum of the rat.

G. Le Fur, A. Uzan, N. Mitrani, 1983, Life sciences.

Evidence for a coupling between dopaminergic receptors and phospholipid methylation in mouse B lymphocytes.

G. Le Fur, A. Uzan, T. Canton, 1981, Life sciences.

Histidine modification with diethylpyrocarbonate induces a decrease in the binding of an antagonist, PK 11195, but not of an agonist, RO5-4864, of the peripheral benzodiazepine receptors.

J. Bénavidès, G. Le Fur, A. Uzan, 1984, Life sciences.

Relationships between plasma corticosteroids and benzodiazepines in stress.

G. Le Fur, A. Uzan, N. Mitrani, 1979, The Journal of pharmacology and experimental therapeutics.

Mezilamine, a new dopamine antagonist, block presynaptic but stimulates postsynaptic α-adrenoceptors

A. Uzan, J. Rataud, J. Mizoule, 1979 .

Fragment recombinant du facteur von Willebrand : un nouvel antithrombotique artériel

A. Schreiber, A. Uzan, C. Prior, 1992 .

Inhibition of Platelet Adhesion to Fibrin(ogen) in Flowing Whole Blood by Arg-Gly-Asp and Fibrinogen γ-Chain Carboxy Terminal Peptides

J. Sixma, P. D. de Groot, A. Uzan, 1992, Thrombosis and Haemostasis.

Binding in vitro of pipequaline (45319 RP) onto plasma proteins and blood cells in man.

S. Urien, J. Tillement, A. Uzan, 1987, Biochemical pharmacology.

Detection of binding sites for spiroperidol on leukemic cells: its value for the phenotype characterization of lymphoid leukemias.

A. Bernadou, A. Uzan, J. Perrot, 1983, Leukemia research.

Guinea pig blood: a model for the pharmacologic modulation of the GPIb/IX-vWF axis.

A. Uzan, L. Drouet, C. Bal dit Sollier, 1996, Thrombosis research.

Synthesis, purification and biological properties of a truncated mutant form of human tissue plasminogen activator produced in E. Coli

B. Cambou, P. Denéfle, A. Uzan, 1991 .

On the regional and specific serotonin uptake inhibition by LM 5008.

G. Le Fur, A. Uzan, M. Kabouche, 1978, Life sciences.

Opposite effects of two ligands for peripheral type benzodiazepine binding sites, PK 11195 and RO5-4864, in a conflict situation in the rat.

G. Le Fur, A. Uzan, C. Renault, 1985, Life sciences.

Partial purification and pharmacology of peripheral-type benzodiazepine receptors.

G. Le Fur, A. Uzan, F. Bégassat, 1987, Journal of receptor research.

[Biotransformation of 10-(3-quinuclidinylmethyl)phenothiazine (LM 209), a new anti-allergy agent and the distribution and excretion of its metabolites].

G. Le Fur, A. Uzan, C. Gueremy, 1976, Xenobiotica; the fate of foreign compounds in biological systems.

[The salt content of food: a public health problem].

A. Uzan, P. Delaveau, 2009, Annales pharmaceutiques francaises.

Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.

M. Taouis, M. Berlan, M. Lafontan, 1989, The Journal of pharmacology and experimental therapeutics.

The unexpected side effects of new nonsteroidal anti-inflammatory drugs

A. Uzan, 2005, Expert opinion on emerging drugs.

Pharmacokinetics and biodistribution of technetium 99m labelled standard heparin and a low molecular weight heparin (enoxaparin) after intravenous injection in normal volunteers

A. Uzan, F. Imbault, B. Bok, 1991, British journal of haematology.

Another link between phospholipid transmembrane migration and ABC transporter gene family, inferred from a rare inherited disorder of phosphatidylserine externalization.

J. Mandel, J. Le Pecq, J. Freyssinet, 1997, Biochemical and biophysical research communications.

[Prevention of experimental thrombosis of the coronary artery, in anesthetized dogs, with a low molecular weight heparin, enoxaparine (PK 10169)].

G. Le Fur, A. Uzan, M. Mestre, 1985, Annales pharmaceutiques francaises.

Pharmacological evidence of a possible tryptaminergic regulation of opiate receptors by using indalpine, a selective 5-HT uptake inhibitor

A. Uzan, M. Kabouche, J. Rataud, 1980, Neuropharmacology.

Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties.

G. Le Fur, A. Uzan, M. Kabouche, 1978, Life sciences.

[3H]spiroperidol binding on lymphocytes: changes in two different groups of schizophrenic patients and effect of neuroleptic treatment.

H. Lôo, É. Zarifian, G. Le Fur, 1983, Life sciences.

2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission—II Biochemical properties

J. Bénavidès, A. Uzan, C. Gueremy, 1985, Neuropharmacology.

Aggregate formation is more strongly inhibited at high shear rates by dRGDW, a synthetic RGD-containing peptide.

J. Sixma, P. D. de Groot, A. Uzan, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

3-(4-Piperidinylalkyl)indoles, selective inhibitors of neuronal 5-hydroxytryptamine uptake.

G. Le Fur, A. Uzan, C. Gueremy, 1980, Journal of medicinal chemistry.

2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission—I Anticonvulsant properties

B. Meldrum, M. Croucher, A. Uzan, 1985, Neuropharmacology.

Are antihistamines sedative via a blockade of brain H1 receptors?

G. Fur, A. Uzan, Christiane Maloouris, 1979, The Journal of pharmacy and pharmacology.

4-Amino-6-chloro-2-piperazinopyrimidines with selective affinity for alpha 2-adrenoceptors.

J. Bénavidès, G. Le Fur, A. Uzan, 1986, Journal of medicinal chemistry.

[ON THE THIAMINES WITH AN OPEN THIAZOLE RING. STUDY OF O,S-DIACETYLTHIAMINE].

A. Uzan, R. Tixier, B. Gauthier, 1963, Annales pharmaceutiques francaises.

Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: Anatomical and subcellular distribution

A. Basbaum, G. Fur, A. Uzan, 1987, Brain Research Bulletin.

Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies.

J. Bénavidès, G. Le Fur, A. Uzan, 1983, Life sciences.

Effects of 4-(3-indolyl-alkyl) piperidine derivatives on brain 5-hydroxytryptamine turnover and on cardiac and brain noradrenaline or 5-hydroxytryptamine depletion induced by 6-hydroxydopamine, H 75/12 and 4-chloroamphetamine.

G. Le Fur, A. Uzan, N. Mitrani, 1977, Biochemical pharmacology.

Study of two new non-steroid anti-inflammatory drugs having a pyrazole structure (LM 22070 and LM 22102).

G. Le Fur, A. Uzan, J. Mizoule, 1979, Archives internationales de pharmacodynamie et de therapie.

Combination of Enoxaparin and Fibroblast Growth Factor-1 Increases Myocardial Blood Flow and Capillary Density after Myocardial Infarction in Rabbits

A. Geist, A. Uzan, J. Haberstroh, 2005, European Surgical Research.

Effect of mequitazine a non sedative antihistamine on brain H1 receptors.

G. Le Fur, A. Uzan, C. Malgouris, 1981, Life sciences.

FM24: A long lasting blocker of rat liver β-adrenoreceptors

J. Hanoune, G. Fur, A. Uzan, 1979 .

Cardiac beta-adrenergic receptor: evaluation of FM 24 as a new and very slowly dissociable blocker.

J. Hanoune, G. Le Fur, A. Uzan, 1978, Life sciences.

Decrease in [3H]ouabain binding sites in heart and brain from spontaneously hypertensive rats

G. Fur, A. Uzan, M. Corgier, 1981, Experientia.

Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic Localization

G. Fur, A. Uzan, C. Malgouris, 1983, Journal of neurochemistry.

Photoaffinity labeling of peripheral-type benzodiazepine-binding sites.

G. Le Fur, A. Uzan, C. Renault, 1987, Molecular pharmacology.

The 5-hydroxytryptamine-releasing properties of two epimer quinoline derivatives

A. Uzan, F. Imbault, C. Renault, 1984, Neuropharmacology.

Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies.

G. Le Fur, A. Uzan, F. Imbault, 1983, Life sciences.

Tissue levels and displacement of in vivo labelled β-adrenergic receptors by FM 24, an irreversible or slowly dissociable β-blocker

G. Fur, A. Uzan, C. Rougeot, 1980 .

Evidence of an increase in brain postsynaptic α‐receptors in spontaneously hypertensive rats

A. Uzan, M. Burgevin, G. Fur, 1980 .

Stereospecificity of the in vitro and in vivo blockade of beta-receptors by FM 24, a slowly reversible ligand.

G. Le Fur, A. Uzan, T. Canton, 1981, Life sciences.

Quantitative Autoradiography of [3H]Indalpine Binding Sites in the Rat Brain: I. Pharmacological Characterization

H. Savaki, G. Le Fur, A. Uzan, 1985, Journal of neurochemistry.

Opposite effects of an agonist, RO5-4864, and an antagonist, PK 11195, of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA/2J mice.

G. Le Fur, A. Uzan, C. Renault, 1984, Life sciences.

Decrease in lymphocyte [3H]spiroperidol binding sites in Parkinsonism.

M. Baulac, V. Meininger, G. Le Fur, 1980, Life sciences.

Multiple benzodiazepine receptors: evidence of dissociation between anticonflict and anticonvulsant properties by PK 8165 and PK 9084 (two quinoline derivatives).

M. Héaulme, G. Le Fur, A. Uzan, 1981, Life sciences.

[Effects of indalpin, a specific 5-HT uptake inhibitor, on the ethanol behavioral dependence and on the voluntary ethanol consumption in rat (author's transl)].

G. Le Fur, A. Uzan, G. Aufrère, 1981, Annales pharmaceutiques francaises.

Stereoselective inhibition of the binding of [3H]PK 11195 to peripheral-type benzodiazepine binding sites by a quinolinepropanamide derivative.

A. Uzan, C. Renault, M. Dubroeucq, 1986, European journal of pharmacology.

Characterization of solubilized "peripheral type" benzodiazepine binding sites from rat adrenals by using [3H]PK 11195, an isoquinoline carboxamide derivative.

G. Le Fur, A. Uzan, C. Renault, 1985, Biochemical pharmacology.

Immunological Investigations of Cytochrome c

A. Uzan, J. Storck, R. Tixier, 1964, Nature.

Differential effects of typical and atypical neuroleptics on alpha-noradrenergic and dopaminergic postsynaptic receptors

A. Uzan, C. Malgouris, M. Burgevin, 1979, Neuropharmacology.

Evidence for an increase in [3H]spiperone binding in hypothalamic nuclei during the development of spontaneous hypertension in the rat.

G. Le Fur, A. Uzan, F. Guilloux, 1983, Clinical and experimental hypertension. Part A, Theory and practice.

Circadian rhythm in the membrane of circulating human blood cells: microviscosity and number of benzodiazepine binding sites. A search for regulation by plasma ions, nucleosides, proteins or hormones.

J. Sulon, F. Lévi, Y. Touitou, 1987, Chronobiology international.

Biochemical evidence that 2-phenyl-4[2-(4-piperidinyl) ethyl]quinoline, a quinoline derivative with pure anticonflict properties, is a partial agonist of benzodiazepine receptors

G. Fur, A. Uzan, C. Malgouris, 1984, Neuropharmacology.

Pharmacological evidence that PK 8165 behaves as a partial agonist of brain type benzodiazepine receptors.

A. Uzan, C. Renault, M. Dubroeucq, 1984, Archives internationales de pharmacodynamie et de therapie.

Serotonin: Change in Plasma‐free Level and Urinary Excretion after LM 5008 and Reserpine

G. Fur, A. Uzan, F. Imbault, 1979, Headache.

Pharmacology of peripheral type benzodiazepine receptors in the heart.

G. Le Fur, A. Uzan, C. Renault, 1985, Progress in clinical and biological research.